{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T09:07:49Z","timestamp":1759482469392},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2006,8,29]],"date-time":"2006-08-29T00:00:00Z","timestamp":1156809600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2007,2,12]]},"DOI":"10.1007\/s00520-006-0126-6","type":"journal-article","created":{"date-parts":[[2006,8,28]],"date-time":"2006-08-28T11:16:05Z","timestamp":1156763765000},"page":"287-291","source":"Crossref","is-referenced-by-count":6,"title":["The outpatient management of low-risk febrile patients with neutropenia: risk assessment over the telephone"],"prefix":"10.1007","volume":"15","author":[{"given":"Toshiro","family":"Mizuno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriyuki","family":"Katsumata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Mukai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chikako","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Ando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,8,29]]},"reference":[{"key":"126_CR1","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1001\/archinte.1988.00380120031007","volume":"144","author":"JA Talcott","year":"1988","unstructured":"Talcott JA, Finberg R, Mayer RJ et al (1988) The medical course of cancer patients with fever and neutropenia: clinical identification of low-risk subgroup at presentation. Arch Intern Med 144:2561\u20132568","journal-title":"Arch Intern Med"},{"key":"126_CR2","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1200\/JCO.1992.10.2.316","volume":"10","author":"JA Talcott","year":"1992","unstructured":"Talcott JA, Siegel RD, Finberg R et al (1992) Risk assessment in cancer patients with fever and neutropenia: a prospective, two center validation of a prediction rule. J Clin Oncol 10:316\u2013322","journal-title":"J Clin Oncol"},{"key":"126_CR3","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/0140-6736(92)90674-R","volume":"339","author":"IA Malik","year":"1992","unstructured":"Malik IA, Abbas Z, Karim M (1992) Randomised comparison of oral ofloxacin alone with combination of parenteral antibiotics in neutropenic febrile patients. Lancet 339:1092\u20131096","journal-title":"Lancet"},{"key":"126_CR4","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1056\/NEJM199907293410502","volume":"341","author":"WV Kern","year":"1999","unstructured":"Kern WV, Cometta A, de Bock R et al (1999) Oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy. N Engl J Med 341:312\u2013318","journal-title":"N Engl J Med"},{"key":"126_CR5","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJM199907293410501","volume":"341","author":"A Freifeld","year":"1999","unstructured":"Freifeld A, Marchigiani D, Walsh T et al (1999) A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy. N Engl J Med 341:305\u2013311","journal-title":"N Engl J Med"},{"key":"126_CR6","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1200\/JCO.1994.12.1.107","volume":"12","author":"JA Talcott","year":"1994","unstructured":"Talcott JA, Whalen A, Clark J et al (1994) Home antibiotic therapy for low-risk cancer patients with fever and neutropenia: a pilot study of 30 patients based on a validated prediction rule. J Clin Oncol 12:107\u2013114","journal-title":"J Clin Oncol"},{"key":"126_CR7","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0002-9343(99)80367-2","volume":"98","author":"IA Malik","year":"1995","unstructured":"Malik IA, Khan WA, Karim M et al (1995) Feasibility of outpatient management of fever in cancer patients with low-risk neutropenia: results of a prospective randomized trial. Am J Med 98:224\u2013231","journal-title":"Am J Med"},{"issue":"Suppl 6","key":"126_CR8","first-page":"17","volume":"6","author":"V Dieras","year":"1997","unstructured":"Dieras V (1997) Docetaxel in combination with doxorubicin. A phase dose-finding study. Oncology 6(Suppl 6):17\u201320","journal-title":"Oncology"},{"key":"126_CR9","first-page":"262","volume":"50","author":"V Dieras","year":"1998","unstructured":"Dieras V, Barthier S, Beuzeboc P et al (1998) Phase I study of docetaxel in combination with doxorubicin as 1st line chemotherapy of metastatic breast cancer. Breast Cancer Res Treat 50:262 (Abstract)","journal-title":"Breast Cancer Res Treat"},{"key":"126_CR10","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1200\/JCO.2000.18.12.2369","volume":"18","author":"JA Sparano","year":"2000","unstructured":"Sparano JA, O\u2019Neill A, Schaefer PL et al (2000) Phase II trial of doxorubicin and docetaxel plus granulocyte colony-stimulating factor in metastatic breast cancer: Eastern Cooperative Oncology Group Study E1196. J Clin Oncol 18:2369\u20132377","journal-title":"J Clin Oncol"},{"key":"126_CR11","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/(SICI)1097-0142(19990101)85:1<213::AID-CNCR29>3.0.CO;2-D","volume":"85","author":"M Hidalgo","year":"1999","unstructured":"Hidalgo M, Hornedo J, Lumbreras C et al (1999) Outpatient therapy with oral ofloxacin for patients with low risk neutropenia and fever. Cancer 85:213\u2013219","journal-title":"Cancer"},{"key":"126_CR12","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1001\/archinte.1995.00430110089009","volume":"155","author":"D Pittet","year":"1995","unstructured":"Pittet D, Wenzel RP (1995) Nosocomial bloodstream infections. Secular trends in rates, mortality, and contribution to total hospital deaths. Arch Intern Med 155:1177\u20131184","journal-title":"Arch Intern Med"},{"key":"126_CR13","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1086\/339215","volume":"34","author":"WT Hughes","year":"2002","unstructured":"Hughes WT, Armstrong D, Body GP et al (2002) 2002 Guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 34:730\u2013751","journal-title":"Clin Infect Dis"},{"key":"126_CR14","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1086\/598624","volume":"29","author":"KVI Rolston","year":"1999","unstructured":"Rolston KVI (1999) New trends in patient management: risk-based therapy for febrile patients with neutropenia. Clin Infect Dis 29:515\u2013521","journal-title":"Clin Infect Dis"},{"key":"126_CR15","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1002\/(SICI)1097-0142(20000401)88:7<1710::AID-CNCR27>3.0.CO;2-1","volume":"88","author":"VM Aquino","year":"2000","unstructured":"Aquino VM, Herrera L, Sandler ES et al (2000) Feasibility of oral ciprofloxacin for the outpatient management of febrile neutropenia in selected children with cancer. Cancer 88:1710\u20131714","journal-title":"Cancer"},{"key":"126_CR16","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1086\/340402","volume":"34","author":"AR Tunkel","year":"2002","unstructured":"Tunkel AR, Sepkowitz KA (2002) Infectious caused by viridans streptococci in patients with neutropenia. Clin Infect Dis 34:1524\u20131529","journal-title":"Clin Infect Dis"},{"key":"126_CR17","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1056\/NEJM199404283301717","volume":"330","author":"A Cometta","year":"1994","unstructured":"Cometta A, Calandra T, Bille J et al (1994) Escherichia coli resistant to fluoroquinolones in patients with cancer and neutropenia. N Engl J Med 330:1240\u20131241","journal-title":"N Engl J Med"},{"key":"126_CR18","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/BF01982191","volume":"13","author":"WV Kern","year":"1994","unstructured":"Kern WV, Markus A, Andriof E (1994) Bacteremia due to fluoroquinolone-resistant Escherichia coli in two immuno-compromised patients. Eur J Clin Microbiol Infect Dis 13:161\u2013165","journal-title":"Eur J Clin Microbiol Infect Dis"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-006-0126-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-006-0126-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-006-0126-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T02:01:38Z","timestamp":1559095298000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-006-0126-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8,29]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,2,12]]}},"alternative-id":["126"],"URL":"https:\/\/doi.org\/10.1007\/s00520-006-0126-6","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,8,29]]}}}